MARKET

HCWB

HCWB

Hcw Biologics Inc.
NASDAQ
0.7731
-0.0275
-3.43%
After Hours: 0.7925 +0.0194 +2.51% 19:27 11/13 EST
OPEN
0.8068
PREV CLOSE
0.8006
HIGH
0.8574
LOW
0.7731
VOLUME
22.46K
TURNOVER
--
52 WEEK HIGH
23.94
52 WEEK LOW
0.7644
MARKET CAP
1.73M
P/E (TTM)
-0.0280
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at HCWB last week (1102-1106)?
Weekly Report · 6d ago
HCW Biologics Inc. Secures up to $10.0 Million in Cash Through Debt Financing
NASDAQ · 11/06 04:58
HCW Biologics Secures Debt Financing to Support Clinical Development
TipRanks · 11/05 14:33
HCW Biologics Announces It Secured $10M In Cash To Finance Its Phase 1 Trial Of HCW9302 To Treat Alopecia Areata
Benzinga · 11/05 13:47
Weekly Report: what happened at HCWB last week (1026-1030)?
Weekly Report · 11/02 10:07
Weekly Report: what happened at HCWB last week (1019-1023)?
Weekly Report · 10/26 10:07
Weekly Report: what happened at HCWB last week (1012-1016)?
Weekly Report · 10/19 10:07
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/13 12:05
More
About HCWB
HCW Biologics Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation, and age-related diseases, such as cancer, cardiovascular diseases, diabetes, neurodegenerative diseases, autoimmune diseases, as well as other conditions. It has developed a Tissue factOr-Based fusion (TOBI) discovery platform to generate designer, novel multi-functional fusion molecules with immunotherapeutic properties. Its lead product candidates include HCW9218 and HCW9302. HCW9218 is a clinical-stage bifunctional molecule that is designed to impact senescence by reducing senescent cells. The Company is prepared to progress HCW9218 in Phase II clinical trials for non-oncology indications.HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes. Its other product candidates include HCW9201, HCW9206, HCW11-006, and others.

Webull offers Hcw Biologics Inc stock information, including NASDAQ: HCWB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, HCWB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading HCWB stock methods without spending real money on the virtual paper trading platform.